The ATM/p53 pathway is commonly targeted for inactivation in squamous cell carcinoma of the head and neck (SCCHN) by multiple molecular mechanisms
- 30 November 2005
- journal article
- Published by Elsevier in Oral Oncology
- Vol. 41 (10) , 1013-1020
- https://doi.org/10.1016/j.oraloncology.2005.06.003
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- The ATM gene is a target for epigenetic silencing in locally advanced breast cancerOncogene, 2004
- Ataxia-Telangiectasia-Mutated ( ATM ) Gene in Head and Neck Squamous Cell CarcinomaCancer Epidemiology, Biomarkers & Prevention, 2004
- TP53 and head and neck neoplasmsHuman Mutation, 2003
- Aberrant Methylation of Gene Promoters in Cancer--Concepts, Misconcepts, and PromiseJNCI Journal of the National Cancer Institute, 2000
- Evidence for a Causal Association Between Human Papillomavirus and a Subset of Head and Neck CancersJNCI Journal of the National Cancer Institute, 2000
- Multiple ATM-Dependent Pathways: An Explanation for PleiotropyAmerican Journal of Human Genetics, 1999
- The use of general primers GP5 and GP6 elongated at their 3' ends with adjacent highly conserved sequences improves human papillomavirus detection by PCRJournal of General Virology, 1995
- Cell Cycle Control and CancerScience, 1994
- The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53Cell, 1993
- WAF1, a potential mediator of p53 tumor suppressionCell, 1993